American Transplant Congress 2009: New Investigator Forum Presents Cutting Edge Research
...tation Controversies Special Interactive Audience Sessions Biologic Immunosuppression Agents NanoMedicine RNA and microRNA biology cholangiocarcinoma in Liver Transplantation Transplant Tourism Clinical Trials Impact of the Acceptable Mismatch in Europe on the Transplantation Rate o...A patient who was diagnosed as IPN-B without hepatolithiasis?
...he bile duct (IPN-B) is a neoplastic lesion preceding invasive intrahepatic cholangiocarcinoma (ICC) and is a new definition of a tumor with papillary growth in the intra...the anterior superior segment (B8), so they strongly suspected intrahepatic cholangiocarcinoma (ICC). Histologically, surgically resected liver specimens, which are deter...Combining liver cancer treatments doubles survival rates, UVA researchers find
...onths. In the study, recently published in the March 2008 issue of Clinical Gastroenterology and Hepatology, 48 patients were treated with advanced cholangiocarcinoma over a five year period. Twenty-nine patients were treated with biliary stents, with the remaining 19 being treated with the stents and photodynamic t...Combined stenting and photodynamic therapy improves survival in late stage liver cancer patients
...or these patients. In this study, 48 patients were treated for advanced cholangiocarcinoma over a five year period. Nineteen were treated with photodynamic therapy (P...bin to less than 75 percent of the pre-treatment value within 30 days. cholangiocarcinoma (cancer of the livers bile ducts) is the second most common liver cancer an...OHSU researchers: Surgery, radiation gives early survival advantage in bile duct cancer
...fic cancer type studied, locoregional extraheptitc cholangiocarcinoma (EHCC), is an uncommon cancer of the bile ducts be...rate of 5 to 10 percent. The reported incidence of cholangiocarcinoma is one to two cases per 100,000 people in the U.S....rofessor of medicine. A total of 2,591 cases of cholangiocarcinoma diagnosed from 1973 to 1998 were taken from the Su...Combination targets: some drugs may work best when they work together
...n antibodies, greatly increases the effectiveness of the antibodies against cholangiocarcinoma (CCA), a rare and deadly cancer of the ducts that drain bile from the liver...iven with or prior to treatment with the human TRAIL-receptor antibodies in cholangiocarcinoma cell cultures. Their findings indicated that treating CCA cell lines with a...Uncooked Fish may Cause Liver Cancer
...ence for eating uncooked fish dishes like koi-pla puts people in SE Asia at risk of ingesting trematodes that can cause a type of liver cancer called cholangiocarcinoma (cancer of the bile ducts), say researchers in this weeks PLoS Medicine. Banchob Sripa (Khon Kaen University) and colleagues discuss the mechanis...Thailand Tops in Rare Type of Cancer
... of Khon Kaen has the world's highest incidence of cholangiocarcinoma - a rare cancer of the bile ducts//, media reports...o a recent Khon Kaen University study, the rate of cholangiocarcinoma in the three villages of Phai, Mancha Khiri and Ch...the district the distinction of being "the world's cholangiocarcinoma basin," said The Nation newspaper. Cholangio...Combined modality approach for effective treatment and enhanced survival in bile duct cancer
... Hilar cholangiocarcinoma is a type of bile duct cancer. Conventional therapy for this for of cancer ...rs for everyone who needs one," says Dr. Rosen. "We feel that patients with cholangiocarcinoma should have equal access to donor organs, because the results are comparabl...New Clinical Studies Confirm Mauna Kea Technologies' Cellvizio(R) GI in Range of Procedures
...ifferentiation of strictures and stenosis, which is one of the most poorly diagnosed GI conditions and can lead to cancers with the poorest prognosis: cholangiocarcinoma or pancreatic cancer. Another study evaluated the ability of Cellvizio(R) GI to evaluate pathologic features of small intestinal pathology (Abstract ...Human Genome Sciences Announces Third Quarter 2007 Financial Results and Key Developments
...eclinical data demonstrating that HGS-ETR1 (mapatumumab) and HGS-ETR2 in combination with chemotherapy synergistically enhanced anti-tumor activity in cholangiocarcinoma (cancer of the bile ducts). In a xenograft model of cholangiocarcinoma, the results demonstrated that HGS- ETR1 and either co-treatment or pre-treatme...